Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0014118 (
endocarditis
)
15,629
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
At Cook County Hospital (Chicago), before 1977, the incidence of
endocarditis
caused by Pseudomonas aeruginosa was one or two cases per year. The frequency of P. aeruginosa as an etiologic agent of
endocarditis
among drug abusers increased steadily from five (23%) of 22 patients in 1977 to 15 (68%) of 22 in 1980. P. aeruginosa serotype
O11
accounted for 34 (76%) of 42 of the strains serotyped. The total increase in incidence of P. aeruginosa
endocarditis
that we observed can be attributed to disease caused by serotype
O11
. We serotyped 152 strains of P. aeruginosa obtained from hospital inpatients without
endocarditis
. Serotype
O11
was the most frequently isolated type, accounting for 27% of the total. Incidence of serotype
O11
in drug addicts with
endocarditis
is significantly higher than the incidence in patients with nonendocarditis infections (chi 2 = 32.89; P less than .001). There was a high degree of correlation between pentazocine and tripelennamine ("T's and Blues") abuse and
endocarditis
caused by P. aeruginosa (chi 2 = 36.71; P less than .001).
...
PMID:Outbreak of endocarditis caused by Pseudomonas aeruginosa serotype O11 among pentazocine and tripelennamine abusers in Chicago. 391 21
Pseudomonas aeruginosa
belongs to the group of three "critical priority" multi-drug-resistant pathogens listed by WHO and is responsible for severe and often deadly infections such as bloodstream infections and pneumonia.
Staphylococcus aureus
is also a "high priority" pathogen which is a major cause of serious nosocomial infections such as bacteremia, sepsis, and
endocarditis
. Owing to their ability to adapt resistance to almost any antibiotics, vaccines against these pathogens are urgently required. These pathogens express structurally unique and densely functionalized glycans on their surfaces which are absent on the host cells. Such carbohydrate antigens are valuable targets for the development of glycoconjugate vaccines and diagnostics. Here, we report the first total synthesis of the conjugation-ready trisaccharide repeating unit of
Pseudomonas aeruginosa
O11
via a highly stereoselective and efficient assembly of a rare l-fucosamine- and d-fucosamine-containing 1,2-
cis
-linked disaccharide motif and its regioselective glycosylation at O3. A systematic study was conducted for the notoriously difficult glycosylation with the most unreactive axial 4-OH of the rare disaccharide, and the successful outcome was utilized to accomplish the total synthesis of an aminopropyl linker-attached trisaccharide repeating unit of
Staphylococcus aureus
capsular polysaccharide type 5, which is also a potential antigen for immunotherapy and vaccine development. The judicious selection of protecting groups and reaction conditions allowed the stereoselective assembly and selective functional group interconversions to access the structurally complex linker-attached trisaccharide repeating units, which are valuable tools for immunological evaluation and vaccine development. The strategy is useful for the synthesis of other structurally related complex glycans.
...
PMID:Total Syntheses of Conjugation-Ready Trisaccharide Repeating Units of
Pseudomonas aeruginosa
O11 and
Staphylococcus aureus
Type 5 Capsular Polysaccharide for Vaccine Development. 3181 59